Dispersible formulations of n-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2- fluoro-4-iodo-phenylamino)-benazmide and uses thereof
US-2024216307-A1 · Jul 4, 2024 · US
Intraocular drug delivery systems
US8969415B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8969415-B2 |
| Application number | US-56591706-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 1, 2006 |
| Priority date | Dec 1, 2006 |
| Publication date | Mar 3, 2015 |
| Grant date | Mar 3, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer.
First claim
Opening claim text (preview).
We claim: 1. A method for treating glaucoma, the method comprising the step of placing multiple biodegradable rod shaped implants side-by-side into the anterior sub-Tenon's region superotemporally 3 to 4 mm from the limbus in the eye, wherein each implant consists of a) 15% by weight bimatoprost; b) 75% by weight RG752S, which is a poly(D,L-lactide-co-glycolide) polymer having a D,L-lactide:glycolide ratio of 75:25 and having an inherent viscosity of between about 0.16 to 0.24 d…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8969415B2 cover?
- Biodegradable implants sized and suitable for implantation in an ocular region or site and methods for treating ocular conditions. The implants provide an extended release of an active agent at a therapeutically effective amount for a period of time between 10 days and one year or longer.
- Who is the assignee on this patent?
- Robinson Michael R, Blanda Wendy M, Hughes Patrick M, and 7 more
- What technology area does this patent fall under?
- Primary CPC classification A61K9/16. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Mar 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).